Paris, France – February 1, 2025 – Koru Pharma successfully concluded its participation at the IMCAS World Congress 2025, held at Palais des Congrès in Paris from January 30 to February 1, 2025.

As one of the leading global events in aesthetic medicine, dermatology, and plastic surgery, IMCAS provided the perfect platform for Koru Pharma to present its latest advancements and groundbreaking solutions.

Located at Booth G107 – Hall Passy A, Koru Pharma welcomed industry professionals, partners, and visitors to explore its innovative product lineup.

Attendees had the opportunity to gain firsthand experience with the company’s latest aesthetic and regenerative medicine solutions, engaging in insightful discussions with experts.

Throughout the three-day event, Koru Pharma showcased its commitment to advancing aesthetic medicine with cutting-edge formulations and high-quality medical devices designed to enhance patient safety, efficacy, and satisfaction.

The event also served as a valuable networking opportunity, strengthening partnerships and paving the way for future collaborations.

Key Product highlights:

• Avalon™ Fillers – Premium dermal fillers for precise contouring and volume restoration.

• RenoXome – Revolutionary exosome-based skincare for deep skin regeneration and rejuvenation.

• Mesoheal® Glow Line – Advanced mesotherapy solutions for radiant, hydrated skin.

• Crystal Healer PN series – Polynucleotide-based treatment for skin repair and regeneration.

• Elitox® – Botulinum toxin designed for effective wrinkle reduction and facial rejuvenation.

Koru Pharma extends its gratitude to all who visited the booth and took part in insightful conversations about the future of aesthetic medicine.